In vitro studies have shown that normal T lymphocytes and their products can augment growth of hematopoietic colony forming units. Small numbers of HLA-compatible T cells and monocytes contaminating in vitro assays can elaborate growth promoting activities in situ, thereby optimizing growth. Various subpopulations of T cells can augment or limit this activity, whereas allosensitized primed T cells (PTC) can inhibit this activity in a target specific manner. Given that these observations have in vivo correlates, these data would suggest that graft failure or graft rejection may not require reactivity against stem cells, but could be mediated by interference with regulatory cell function. To address this issue, we propose to identify cellular interactions critical for establishing marrow allografts with particular emphasis on the positive and negative roles T cells may play in this process. In vivo antibody facilitate marrow engraftment in SL/SL mutant mice will be used to identify critical regulatory cells required for proper hematopoiesis and determine how defined populations of T cells effect their function. We will try to establish a human correlate by defining the phenotype and function of cells associated with marrow failure in patients receiving T-cell depleted marrow or unmanipulated HLA-nonidentical marrow. Additional studies using lymphocytes stimulated by alloantigens in vitro will focus on the cellular signals that elicit pertinent T cell responses, the phenotype of the effectors, and the mechanism by which they influence hemtopoietic colony growth. We believe these studies will provide a more complete understanding of the cellular interactions critical for sustained engraftment and will contribute directly to improving the efficacy of marrow transplantation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA018221-15
Application #
3811918
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
15
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
075524595
City
Seattle
State
WA
Country
United States
Zip Code
98109
Mielcarek, Marco; Storer, Barry E; Boeckh, Michael et al. (2009) Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes. Blood 113:2888-94
Tseng, Li-Hui; Storer, Barry; Petersdorf, Effie et al. (2009) IL10 and IL10 receptor gene variation and outcomes after unrelated and related hematopoietic cell transplantation. Transplantation 87:704-10
Bensinger, W I (2009) Role of autologous and allogeneic stem cell transplantation in myeloma. Leukemia 23:442-8
Bensinger, William (2008) Stem-cell transplantation for multiple myeloma in the era of novel drugs. J Clin Oncol 26:480-92
Storek, Jan (2008) Immunological reconstitution after hematopoietic cell transplantation - its relation to the contents of the graft. Expert Opin Biol Ther 8:583-97
Bensinger, William I (2007) Is there still a role for allogeneic stem-cell transplantation in multiple myeloma? Best Pract Res Clin Haematol 20:783-95
Carpenter, Paul A; Hoffmeister, Paul; Chesnut 3rd, Charles H et al. (2007) Bisphosphonate therapy for reduced bone mineral density in children with chronic graft-versus-host disease. Biol Blood Marrow Transplant 13:683-90
Bensinger, William I (2007) Reduced intensity allogeneic stem cell transplantation in multiple myeloma. Front Biosci 12:4384-92
Zaucha, Renata E; Buckner, Dean C; Barnett, Todd et al. (2006) Modified total body irradiation as a planned second high-dose therapy with stem cell infusion for patients with bone-based malignancies. Int J Radiat Oncol Biol Phys 64:227-34
Alkindi, S; Deeg, J H; Flowers, M E D (2006) Recovery of normal autologous myelopoiesis after graft rejection following allogeneic bone marrow transplant for agnogenic myeloid metaplasia. Clin Lab Haematol 28:134-7

Showing the most recent 10 out of 692 publications